In China, vaccine research, test, approval and production are supervised by the drug inspection system, while vaccination and transportation are mainly supervised by the health system. Vaccine supervision needs to be completed jointly by the drug supervision department and the health department. How to coordinate the supervision scope of the two departments and avoid the blind spot in supervision is very important for the vaccine management in the future market circulation.
The meaning of the above paragraph is that the lack of communication and coordination between the drug supervision system and the health system has resulted in a blind spot in market supervision.